Profile of Cardiac Involvement in Children After Exposure to COVID-19

Munesh Tomar1, Maitri Chaudhuri2, Tanvi Goel3

  • 1Department of Pediatrics, LLRM Medical College, Meerut, Uttar Pradesh. Correspondence to: Dr Munesh Tomar, Consultant, Pediatric Cardiologist, LLRM Medical College, Meerut, Uttar Pradesh 250 002. drmuneshtomar@gmail.com.

Indian Pediatrics
|March 10, 2023
PubMed

Insights

Post-COVID-19 in children, cardiac involvement is common and often undetected. Early echocardiography is crucial for diagnosis and treatment, leading to favorable outcomes and high survival rates in multisystem inflammatory syndrome in children (MIS-C).

Area of Science:

  • Pediatric Cardiology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • The coronavirus disease (COVID-19) pandemic has raised concerns about potential long-term health effects in children.
  • Multisystem inflammatory syndrome in children (MIS-C) is a rare but serious condition associated with COVID-19, often involving cardiac complications.

Purpose of the Study:

  • To determine the frequency and types of cardiac issues in children following COVID-19 infection.
  • To assess the effectiveness of early diagnostic and treatment strategies for pediatric cardiac involvement post-COVID-19.

Main Methods:

  • A prospective observational study was performed at a tertiary care hospital in India.
  • Consecutive children with suspected MIS-C referred to cardiology services were included.
  • Cardiac assessments included echocardiography to identify abnormalities.

Main Results:

  • Out of 111 children studied, 95.4% exhibited cardiac involvement.
  • Common abnormalities included coronary vasculopathy, pericardial effusion, ventricular dysfunction, and pulmonary hypertension.
  • The survival rate post-treatment was 99%, with most cardiac parameters improving.

Conclusions:

  • Cardiac involvement following COVID-19 in children can be asymptomatic and requires specific evaluation.
  • Early echocardiography is vital for timely diagnosis, management, and achieving positive outcomes in pediatric MIS-C.
  • Prompt intervention significantly improves cardiac function and survival rates.
Abstract

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
16
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
11
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
14
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
20
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
18
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
39